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AIM To establish a patient-centered research agenda for cerebral palsy (CP).  
METHOD We engaged a large cross-section of the extended community of people 
living with CP and those providing healthcare to people with CP (‘the community’) in an 
educational series and collaborative survey platform to establish an initial list of 
prioritized research ideas. After online workshops, a facilitated Delphi process was used 
to select the 20 highest priorities. Select participants attended an in-person workshop to 
provide comment and work toward consensus of research priorities.  
RESULTS A research agenda for CP was developed by the community, which included 
consumers, clinicians, and researchers interested in advancing the established 
research agenda. The results included the top 16 research concepts produced by the 
process to shape and steward the research agenda, and an engaged cross section of 
the community. 
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INTERPRETATION It has been shown that proactively engaging consumers with 
clinical researchers may provide more meaningful research for the community. This 
study suggests that future research should have more focus on interventions and 
outcomes across the lifespan with increased emphasis on the following outcome 
measures: function, quality of life, and participation. 
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What this paper adds  
 • Comparative effectiveness of interventions, physical activity, and understanding 
ageing were leading themes. • Longitudinal studies across the lifespan, clinical spectrum, and ages were highly 
ranked.  • Participants reported high value for participation outcomes. • Participants reported great appreciation for the engagement between consumers 
and clinician researchers.  
 
[main text] 
Cerebral palsy (CP) is an umbrella term for non-progressive, permanent brain disorders 
that affect development of movement and posture and precipitate a host of secondary 
and chronic comorbidities.1 A recent article reports that public funding of CP research 
between 2001 and 2013 increased but that funding for studies of clinical interventions 
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comprised only 19 percent of the funding and CP in adulthood comprised only 4 
percent.2 A survey of an online community of parents and caregivers (n=1214) of 
children with CP conducted by the nonprofit organization CP NOW found that available 
medical information was judged by survey respondents (parents) to be inadequate to 
guide medical decision making for children with CP.3
 Patient and caregiver involvement in the development of research is vital to 
producing research that improves the health and well-being of all patient populations,
 Perceived inadequacy of available 
information reported by survey respondents may be attributable to the diversity of 
clinical presentations in this population, the broad array of treatments and medical 
providers involved in care of persons with CP, the lack of comparative effectiveness 
research for treatments, and the long-term, progressive nature of CP sequelae. 
Regardless of cause, perceived inadequacy of information points to the need for a 
research agenda involving the extended community of people living with CP and those 
providing healthcare to people with CP that informs medical decision making for 
persons with CP. 
4 
and, more specifically, for those with disabilities.5 However, efforts toward this end are 
somewhat limited. To date, three groups have published the results of their efforts that 
included persons with CP and their caregivers in the development of research agendas. 
Two of these efforts were focused broadly on neurodisability rather than specifically on 
CP and included caregivers and persons with several neurodevelopmental conditions.6,7 
The third effort focused specifically on CP in Australia8 and may have limited 
generalizability outside of the Australian healthcare context. In addition, the McIntyre et 
al.8 study was conducted 10 years ago and differed from others in that it did not include 
an in-person meeting. It is possible that these meetings may foster a deeper 
understanding of various perspectives9
 The Patient-Centered Outcomes Research Institute was established to promote 
comparative clinical effectiveness research that informs healthcare decisions. The 
Patient-Centered Outcomes Research Institute granted an award to the Cerebral Palsy 
Research Network (CPRN) and CP NOW to develop a patient-centered research 
agenda for CP. Called ‘Research CP’ for short, the effort sought to bring together and to 
 since they facilitate thoughtful information 
exchanges and the opportunity for creating relationships among stakeholders. 
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engage persons with CP and their caregivers, clinicians, scientists, policy makers, and 
advocates in the development of a patient-centered comparative effectiveness research 
agenda. The theoretical basis of ‘Research CP’ builds on the idea of ‘nothing about us 
without us.’ Research CP offers two enhancements to improve outcomes of the agenda 
creation effort: (1) educating the community (consumers, researchers, and clinicians) to 
give everyone basic information in order to inform the process of research idea 
generation and prioritization; and (2) developing and confirming the agenda together – 
having consumers, researchers, and clinicians working together at every step, from 
development of the concept of Research CP through education, idea generation, the 
Delphi process of bringing forth best ideas, and then confirmation of priorities. Because 
the authors believe a research agenda created with consumers would be more 
important and engaging to the entire community than one developed by professionals 
alone, we undertook a process to create such an agenda.  
 
METHOD  
This study utilized a community-based participatory approach combined with consensus 
building activities. The community included consumers (caregivers and persons with 
CP), professionals (clinicians and researchers), and advocates. Development of the 
research agenda included four steps: (1) conduct a series of online webinars to educate 
stakeholders about clinical trial design and comparative effectiveness research, patient 
registries, patient reported outcome measures and patient-centered research, the state 
of publicly funded CP research, collaborative research, and quality networks; (2) elicit 
from the larger community about research priorities for CP; (3) convene an in-person 
workshop to set a clinical research agenda that synthesizes elicited perspectives and 
establishes an engaged team of stakeholders; and (4) broadly disseminate results 
outlining the community’s shared clinical effectiveness research agenda for CP. 
 
Webinar series 
Participants (n=275) were recruited from advocacy organizations, from the American 
Academy for Cerebral Palsy and Developmental Medicine, from Facebook groups, via 
advertising, and from followers of the CPRN and CP NOW websites. Participants 
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included those who participated in any of five live webinars as well as those who viewed 
recorded webinars after live presentations. There were five webinars: (1) an overview of 
the Research CP initiative, outlining the time commitment and objectives of the 
program, and after the first webinar, successive overviews of (2) methods for clinical 
comparative effectiveness research, (3) quality improvement, (4) patient-centered 
research and outcomes, and (5) clinical and patient-reported outcome registries. Active 
question and answer periods followed each webinar, along with a short posttest 
designed to reinforce learning and ensure engagement. 
 
Generation, consolidation, and prioritization of research ideas  
After the first webinar, those participants were invited to contribute to an iterative online 
process via Codigital Ltd. Codigital is an online external crowdsourcing intermediary that 
provided an independent platform for users to openly record, edit, and vote on each 
other’s ideas allowing for the most prominent ideas to emerge naturally. Participants in 
the generation and prioritization processes are detailed in Table I. Initially, two 
questions were posed to elicit ideas: (1) What research questions are most important to 
you? and (2) If you could identify one area to improve in the care or treatment of people 
with CP, what would that be? These questions were purposefully written to engage 
researchers/clinicians by asking about research and consumers by asking about 
desired improvements to care or treatment in a language more familiar to their 
experience. Subsequently, over the next 20 days, participants received daily email 
messages notifying them of the opportunity to contribute new questions, edit existing 
questions, or vote on proposed ideas. Consumers, clinicians, and researchers all saw 
and participated in creating and voting on new questions in either domain. Overall, 392 
ideas were generated, and 26 798 votes were cast in the paired comparison process 
that Codigital utilized to prioritize ideas elicited from the field. 
 The Research CP leadership team (six members: two each of consumers, 
clinicians, and researchers) participated in a facilitated Delphi process to eliminate 
redundancy and reduce the set of ideas to a number manageable for consideration in 
the in-person workshop. Several ideas that were more related to advocacy and 
education, as well as those that suggested guidelines development rather than new 
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research, were not included in the list for consideration at the workshop. After 
organization and consolidation, the Delphi process produced 20 highest-ranking, unique 
ideas to be brought forward for consideration and confirmation by workshop 
participants. (See Appendix S1, online supporting information, for complete ranked, 
consolidated, and categorized lists). 
 
In-person workshop 
Eighty-three applications were received for the in-person workshop in Chicago in June 
2017. Applications were evaluated by the leadership team based primarily on webinar 
attendance, postwebinar survey completion, and engagement in the idea 
generation/refinement process. Engagement was measured by Codigital by assigning 
an engagement rank (Table I). Applicants were then categorized by type 
(patient/caregiver, provider/researcher, patient advocate), role (e.g. parent, caregiver, 
person with CP, clinical discipline), age of person with CP, severity of CP, ethnic group, 
and geographical factors to achieve a representative group of workshop participants. 
Invitations to the workshop were extended to 43 people including three personal care 
assistants; 41 could attend. With the leadership team, there were a total of 47 attendees 
not including the facilitator and a science writer.  
 At the workshop (see agenda in Appendix S2, online supporting information), the 
facilitator led a process designed to gather more detailed information and perspectives 
on the 20 highest-ranking research ideas. The facilitator not only guided the agenda but 
also assured that all opinions were heard throughout the meeting. After introductions, 
the leadership team reviewed with the full group of meeting participants the idea 
generation and synthesis processes that took place over the full period of participant 
engagement. In advance of the workshop, all participants submitted a description of 
their challenges with CP and desired outcomes for the workshop that was distributed 
with prereading materials. A subset of participants was asked to share their 
submissions aloud to set a tone of openness for the workshop. After the group 
discussion, suggestions on moving the research ‘concepts’ to actionable research 
‘questions’ were discussed. 
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 The full group was subsequently divided into four subgroups designed to include 
a diversity of consumer and clinician/researcher perspectives. Subgroups were 
facilitated by leadership team members. Each subgroup was asked to review a different 
subset of the highest-ranking research ideas. The groups discussed the intended 
meaning of the ideas and how they might best be applied in research. After these 
breakouts, the full group reconvened, and subgroups reported the results of their 
discussions including redundancies within the list of ideas. Discussion and consolidation 
produced a final list of highest research priorities. 
 The meeting facilitator then asked for each participant to summarize his or her 
most impactful observation from the whole experience. These observations were written 
on flip charts and consolidated in real time as a group. The meeting concluded with 
detailed exploration of the top three research concepts, including options to further 
narrow the concepts as well as study design and implementation issues. Examples of 
how CPRN infrastructure could accelerate development of the study were discussed. 
These examples were linked to how Research CP would provide a pool of interested 
and engaged patient stakeholders to participate in future research and dissemination 
efforts. In addition, next steps were presented, including preparation of a manuscript 
detailing the process and results, and how attendees could not only stay engaged in the 
conversation but also stay abreast of progress of the project and its intended impact on 
the resultant CP research agenda. 
 
RESULTS  
A summary of the process and participants at each stage is illustrated in Figure 1. Table 
I describes the great diversity in backgrounds and experiences of community 
participants and professional disciplines represented. There was also diversity in age, 
level of professional experience, and other factors that created greater representation of 
varied outlooks in the process.  
 Table II lists the top-ranked research ideas that resulted from the participatory 
action research methodology. Lifespan issues and longitudinal studies from childhood to 
adulthood were prioritized by Research CP participants. The focus on adulthood comes 
both from our adult participants, who desire more information about their current state, 
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and participants who are parents of young children who wish to know more about their 
child’s future. These issues included questions related to symptoms such as pain and 
fatigue, as well as exercise, health, and wellness. There was a strong appreciation for 
the value of engagement between consumers and clinician researchers to further 
sharpen this agenda and make resultant research most meaningful and impactful. 
Participation outcomes were highly valued, particularly by our consumer participants. 
 Common observations shared by participants at the end of the meeting included 
the following: a desire to keep the momentum and community partnership moving 
forward, longitudinal studies across the age span and the clinical spectrum should drive 
research, the importance of the adult perspective including the cascading loss of 
function, and emphasizing participation as an important outcome measure.  
 
DISCUSSION 
This report describes the development of a research agenda for CP using a highly 
interactive consumer/clinician/investigator partnership. The study highlights the need to 
focus on longitudinal research that includes outcomes related to participation and 
quality of life. To our knowledge, only one other group has published their efforts to 
establish a prioritized research agenda specific to CP.8 That work differed from this 
study in several ways. Firstly, it involved only Australian participants who receive care in 
a socialized healthcare system and may have a different outlook on medical care and 
what it can and should do for individuals with CP. Secondly, the Australian study 
analyzed themes within two segregated participant groups. For example, Australian 
consumers identified questions in themes of prevention or cure, quality of life or 
community participation, and service provision or intervention, whereas intervention 
researchers or clinicians identified questions in themes of effective outcomes and 
effective research or services. The Research CP effort reflected group consensus with 
combined input from all participants to reach its conclusions. Thirdly, Research CP was 
limited to clinical research questions rather than including basic and translational 
research topics. Accordingly, results reflect a strong bias toward clinical questions with 
existing interventions. Finally, the Australian consensus process did not include in-
person meetings, which Research CP participants considered an integral part of the 
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process. A key takeaway noted by many Research CP participants was an increased 
appreciation and respect of the partnership between consumers and 
clinician/researchers, which participants were eager to continue going forward.  
 Despite these marked differences, there was considerable concordance between 
the Australian and Research CP efforts. Both efforts highly prioritized areas of quality of 
life and participation, and service delivery and intervention – specifically dose, 
alternative treatments, and pain. A major difference between the efforts was the strong 
value placed in the Research CP effort on the need for longitudinal work that examines 
outcomes across the lifespan. There were also similarities between outcomes of the 
Research CP effort and the two reports focused more broadly on neurodisability, 
including a focus on comparative effectiveness studies. 
 Outcomes such as decreased tone, improved reach kinematics, or increased 
range of motion generated much less enthusiasm than participation outcomes in the 
study, even though those former outcomes are generally the more direct targets of most 
medical therapies and therapeutic interventions. Although clinicians hope that improved 
body function and structure will increase participation, this has yet to be demonstrated.10 
Moreover, participation can be targeted directly through adaptation rather than indirectly 
via attempts to change body structure and function.11
Within the overarching priority of longitudinal outcomes, several themes were 
identified. Firstly, we need better understanding of the etiology and treatment of those 
issues that are commonly seen in adults with CP. The group clearly identified chronic 
pain that interferes with life participation, fatigue, and depression as critical problems. 
There was great interest in exercise and fitness, and early functional loss, all of which 
are well described in adults with CP.
 The discussions, both through 
idea generation and at the workshop, indicate that a focus on more work to determine 
best practices for improving participation, especially at the intersection of participation 
and technology, is of paramount importance. Fortunately, there has been a shift from 
body structure and function measures to participation measures in research related to 
disability, and future work in CP will need to continue that trend. 
12,13 Secondly, more research is needed into 
pediatric interventions and how they influence adult outcomes. Some work has been 
done in this area, including studies of selective dorsal rhizotomy14,15 and intrathecal 
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baclofen.16 Much more research needs to focus on this area, including studies of 
intensive therapy interventions and other treatments into which families heavily invest 
their time and resources with the hope of maximizing their child’s potential as an adult. 
Thirdly, there were many questions about physiology of the ageing process combined 
with a developmental neurologic disorder such as CP. There is evidence of increased 
risk of chronic cardiovascular and musculoskeletal disease in adults with CP.17 It is 
known that muscles, bones, joints, and most body systems are affected by both 
processes, but the community needs to know more about prevention and treatment. 
Finally, emphasis on participation suggests that we need greater information about 
psychosocial issues related to growing up with CP including employment, relationships, 
and best practices for encouraging independence. The existing literature suggests that 
much more needs to be done to help adults with CP.18,19
 Questions such as adult outcomes and relationships between interventions and 
participation are difficult to answer unless the investigation involves large populations 
followed over time. Both clinical interventions and adults with CP were identified as 
underfunded topics by Wu et al.,
 This emphasis on lifespan 
studies (referenced specifically in half of the research ideas, Table II), combined with 
the desire for work that focuses on participation as noted above, prioritizes the need to 
validate and implement a set of participation measures for longitudinal study of 
outcomes for individuals with CP.  
2 which is consistent with what the community 
prioritized as top research ideas. This consumer driven agenda is different than current 
directions in CP research, in that it emphasizes prioritization for longitudinal work across 
the lifespan. A recent review of 2016 funded projects in CP20
The lack of studies addressing lifespan issues is perhaps due to the structure of 
most public funding mechanisms that typically fund for periods between 1 and 5 years 
and are not conducive to longitudinal studies across the lifespan. The consumer driven 
agenda from this study suggests the need to shift the focus and consider different 
funding mechanisms across a greater number of years to address lifespan and 
longitudinal research in this population.  
 demonstrates that only 3 
of 74 projects funded (4%) were specific to adults, and none were longitudinal studies or 
addressed lifespan issues from childhood to adulthood. 
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Limitations 
The Codigital voting tended to favor broad research questions over more actionable 
narrowly defined questions. Consequently, certain research topics, very important to a 
smaller slice of participants, may not have been represented in the top 100 even though 
they are very ‘patient-centered’. The leadership group considered bringing some of 
these ‘underserved’ questions forward for discussion but decided to honor the ranking 
system (see Appendix S1, online supporting information). 
 Contributions to the agenda through Codigital were influenced by the number 
and engagement of groups of participants. Amongst clinicians, some disciplines were 
more heavily represented and had more impact on the ideas and rankings. This may 
have occurred because of differences in recruiting efforts between disciplines, and other 
factors beyond the control of the leadership team. It is notable, however, that the 
rehabilitation disciplines that spend significant time with patients with CP over the 
lifespan (e.g. physical therapy, occupational therapy, physiatry) contributed significantly 
to the list of priorities. The differential contribution of the various professionals was 
balanced by the fact that the consumers contributed more than 60 percent of the 
resultant agenda. See participant description (Table I) to see relative contribution of 
various audiences. 
 Promotion of the initiative and engagement in the process required frequent 
email access and initial contact via e-mail or social media. It is likely that consumer 
participants represented a selection bias common to social media outlets targeted for 
participants (trending toward white, middle-income women). While there were parents of 
teens participating, the authors are not aware of any teens participating directly so that 
important voice was missing. Funding limitations of the workshop may have reinforced 
this bias by bringing together only those who were most engaged in the digital portion of 
the process.  
 
Next steps and conclusion  
The CPRN registry, created as a result of development of the National Institutes of 
Health Strategic Plan for CP,21 captures a breadth of patient characteristics, 
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interventions, and patient reported outcomes. Use of these evolving data sets to provide 
unique insights into long-term outcomes from interventions, and effects of various 
medical issues and environmental factors for people with CP throughout their lifespan, 
are encouraged in two recent National Institutes of Health strategic plans.21,22
 Potential benefits of patient-centered research were strongly reinforced by the 
Research CP initiative. The partnership formed between consumers and clinician 
researchers was invaluable not only to set the research agenda but also for the 
potential to develop relationships that will enable collaboration in the development of 
studies that stem from these priorities. This study provides a guide for important 
research for CPRN and the field of CP to improve care and outcomes for individuals 
within this population. 
 CPRN’s 
community registry provides a platform to continue longitudinal studies focused on 
outcomes after transition from a pediatric to adult care center. It enables linkage of 
those long-term patient reported outcomes to clinical registry data collected from the 
point of their diagnosis with CP. It will provide an important tool for investigators to 
answer questions identified in this effort as highest priority to consumers and 
clinicians/researchers. 
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Appendix S2: Workshop agenda 
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Table I: Participant description in Research CP initiative 
 
Type of participant Webinar 
participants 
Codigital 
participants 
% 
contributiona 
Workshop 
participants 
Parent or caregiver of a person with 
CP 
99 72 31.91 15 
Person with CP 38 33 27.60 6 
Clinician, therapist, or researcher 132 93 38.76 23 
CP community advocate 6 4 1.73 3b 
Total 275 202 100 47 
GMFCS levelc     
I N/A 4 3.41 0 
II N/A 35 13.78 3 
III N/A 19 15.64 5 
IV N/A 18 10.95 9 
V N/A 25 12.42 3 
Unknown GMFCS N/A 4 1.08 1 
Average/median age of person with 
CP 
N/A 46/48 N/A 52.2/49 
Average/median age of person with N/A 13/10 N/A 13.6/14 
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CP represented by parent/caregiver 
Clinician/researcher disciplines     
Complex care pediatrics 2 1 0.01 0 
Developmental pediatrics 10 6 0.36 3 
Neurology 2 2 2.72 2 
Neurosurgery 3 2 0.82 2 
Nursing 3 2 5.56 0 
Occupational therapy 11 9 5.08 1 
Ophthalmology 1 1 0.18 0 
Orthopedic surgery 11 8 1.97 2 
Orthotics 1 1 0.43 0 
Physical medicine and rehabilitation 17 9 6.39 3 
Physical therapy 50 37 11.90 4 
Research 17 10 3.01 5 
Speech and language therapy 4 0 0.00 1 
PT/research administration 0 1 0.05 0 
Speech-language pathology and 
audiology 
0 2 0.17 0 
Speech language/feeding therapy 0 1 0.04 0 
 
aThe overall percentage contribution is calculated from (1) the contribution to the 
content of the top ideas and (2) the contribution to the voting that put those ideas to the 
top. Codigital imposed limits on voting to prevent a participant from having too great an 
impact on rankings. The percentages sum to 100% so this column demonstrates how 
much impact any one cohort had on the final research agenda. bAll three CP community 
advocates were also parents of children with CP. c
 
GMFCS level was both for the people 
with CP that participated, and those people represented by parents and caregivers. CP, 
cerebral palsy; GMFCS, Gross Motor Function Classification System; PT, physical 
therapy.  
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Table II: Top 16 research ideas
 
a 
Number Research ideas Codigital 
question 
Codigital 
rank 
1 Research the issues around ageing with CP, to 
understand not only how to treat adults now, but 
also to update our treatments & therapies with 
children who have CP to prevent some of the 
secondary impairments such as pain, fatigue, and 
functional loss. 
Care 
Treatment
1 
b 
2 What are the best long-term exercise/strength 
training strategies to improve activity, participation 
and health, minimize pain, and maximize function in 
each GMFCS category across the lifespan? 
Research 1 c 
3 Which interventions (surgeries, injections, 
medications and therapies [orthotics, equipment, 
training]) are associated with better functional 
outcomes (important to child/family) controlling for 
GMFCS level, age, and comorbidities 
Research 2 
4 Increasing age is related to pain and fatigue in 
people with CP, regardless of GMFCS level. What 
variables are important to monitor/treat early on in 
life to prevent the development of pain and fatigue 
later on in life? 
Research 4 
5 What are the best methods and ways to reduce 
pain, falling, lack of stamina, and deterioration of 
function that can have a negative impact on the 
quality of life for people with CP especially in 
adulthood? 
Research 5 
6 Research effective ways to build and maintain Care 6 
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strength, flexibility, and endurance health in children 
and adults with CP. How can we find better ways to 
successfully integrate these into daily living? 
treatment 
7 Develop and test effective methods for exercise and 
increased physical activity for individuals who are 
less ambulatory (some GMFCS III, and GMFCS IV 
and V) including techniques, proper dosing, and 
information on effects on strength and health. 
Research 7 
8 How can we best leverage the brain's neuroplasticity 
to retrain neural pathways for improved motor 
function, speech function, and mobility? 
Research 8 
9 Have large-scale studies that follow children with the 
various types of CP throughout adulthood to 
discover how the ageing process affects individuals 
with different types of CP and severity levels. 
Care 
treatment 
11 
10 What are effective treatment methods to address 
differential outcomes in adolescents and adults 
related to pain, fatigue, and early functional loss? 
Research 11 
11 Study the outcomes of complementary and 
nontraditional therapies, i.e. hyperbaric oxygen, 
hippo, swimming/aquatic, Feldenkrais, massage, 
yoga, Tai Chi, music, recreational, acupuncture, etc. 
Review efficacy, costs, insurance support 
probabilities. 
Care 
treatment 
12 
12 Research the effectiveness of intensive physical 
therapy programs, bursts of services, combined 
protocols (i.e. botulinum neurotoxin with intensive 
PT, etc.). Evidence of efficacy is needed to get ALL 
insurers to fully cover the treatment options that 
work. 
Research 13 
13 How do we best maximize functional independence Care 15 
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and life participation of children and adults with CP? treatment 
14 Identify biomarkers (neuroimaging, blood, CSF, 
amniotic fluid) to help determine which individuals 
respond best to which interventions (therapy, 
medical, surgical) so that treatment approaches can 
be tailored to each individual person with CP. 
Care 
treatment 
18 
15 Quality of life is an important goal for a number of 
questions related to CP. How do we quantify that so 
that we can really answer which interventions 
produce the greatest benefit to quality of life? 
Research 18 
16 Not much work has been done on the cognitive 
impairments including difficulties with math and any 
subject with spatial orientation. 
Research 21 
 
aTop 16 research ideas table lists equally ranked ideas from Codigital in alphabetical 
order of top level questions, i.e. care treatment ideas of equal rank to research ideas 
are listed first. bCare treatment 1 refers to the top ranked (based on votes) research 
idea in answer to the question: If you could identify one area to improve in the care or 
treatment of people with CP what would that be?  c
 
Research 1 refers to the top ranked 
(based on votes) research idea in answer to the question: What research questions are 
most important to you? CP, cerebral palsy; GMFCS, Gross Motor Function 
Classification System; PT, physical therapy; CSF, cerebrospinal fluid. 
[figure legend] 
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Figure 1 Flow chart showing the process and numbers of participants and results at each 
stage 
 
 
 
 
 
 
Webinar 
Series  
• 275 participants.  
• Basic education on the initiative, comparative effectiveness research, quality 
improvement, patient-centered research and patient-centered outcomes, and patient 
registries. 
Survey  
• 201 participants genterated 392 ideas via CoDigital over a 20 day period. 
• Ideas were generated under either 'What research questions are most important to 
you?' or 'If you could identify one area to improve in the care or treatment of people 
with CP, what would that be?' 
In Person 
Workshop  
• 83 applications submitted. 
• 47 attendees. 
• Generated top 16 research ideas. 
• Generated list of key takeaways from in person workshop. 
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